Epsilon M&A Deal Report - SGD Pharma
Transaction Multiples for the Valuation of Private Companies
Private groupe led by China Jianyin Investment / SGD Pharma
No EMAT :
78915
Announced Date :
10/05/2016
Type :
SBO (Secondary Buy Out) ,Exit
Deal Value :
Yes
Acquirer :
Private groupe led by China Jianyin Investment
Target :
SGD Pharma
Country :
France
Sector of activity :
- Packaging & Containers > Containers, Packaging & Paper Industries > Industrial Goods > Glass Packaging Manufacturers
Business Description :
SGD Pharma manufactures molded and converted primary glass packaging for the pharmaceutical industry. > Now focused on products dedicated to the largest pharmaceutical companies worldwide since the...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
|
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Glass Packaging Manufacturers » = 21
| Date | Acquirer | Target | Country | Multiples | See details |
| 12/05/2015 | Private Group Led by Advent International | Ammeraal Beltech | Netherlands | * | 78885 |
| 01/07/2014 | Precia Molen | Antignac Pesage | France | * | 78377 |
Source: Epsilon Research / EMAT
